214 related articles for article (PubMed ID: 22230570)
21. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition.
Borg NA; Ely LK; Beddoe T; Macdonald WA; Reid HH; Clements CS; Purcell AW; Kjer-Nielsen L; Miles JJ; Burrows SR; McCluskey J; Rossjohn J
Nat Immunol; 2005 Feb; 6(2):171-80. PubMed ID: 15640805
[TBL] [Abstract][Full Text] [Related]
22. Directed evolution of a stable scaffold for T-cell receptor engineering.
Shusta EV; Holler PD; Kieke MC; Kranz DM; Wittrup KD
Nat Biotechnol; 2000 Jul; 18(7):754-9. PubMed ID: 10888844
[TBL] [Abstract][Full Text] [Related]
23. Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22.
Adams EJ; Chien YH; Garcia KC
Science; 2005 Apr; 308(5719):227-31. PubMed ID: 15821084
[TBL] [Abstract][Full Text] [Related]
24. Directed evolution of human T cell receptor CDR2 residues by phage display dramatically enhances affinity for cognate peptide-MHC without increasing apparent cross-reactivity.
Dunn SM; Rizkallah PJ; Baston E; Mahon T; Cameron B; Moysey R; Gao F; Sami M; Boulter J; Li Y; Jakobsen BK
Protein Sci; 2006 Apr; 15(4):710-21. PubMed ID: 16600963
[TBL] [Abstract][Full Text] [Related]
25. Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells.
Nag B; Kendrick T; Arimilli S; Yu SC; Sriram S
Cell Immunol; 1996 May; 170(1):25-33. PubMed ID: 8660796
[TBL] [Abstract][Full Text] [Related]
26. In vitro evolution of a T cell receptor with high affinity for peptide/MHC.
Holler PD; Holman PO; Shusta EV; O'Herrin S; Wittrup KD; Kranz DM
Proc Natl Acad Sci U S A; 2000 May; 97(10):5387-92. PubMed ID: 10779548
[TBL] [Abstract][Full Text] [Related]
27. Construction and screening of an antigen-derived peptide library displayed on yeast cell surface for CD4+ T cell epitope identification.
Wen F; Zhao H
Methods Mol Biol; 2013; 1061():245-64. PubMed ID: 23963942
[TBL] [Abstract][Full Text] [Related]
28. Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.
Gras S; Saulquin X; Reiser JB; Debeaupuis E; Echasserieau K; Kissenpfennig A; Legoux F; Chouquet A; Le Gorrec M; Machillot P; Neveu B; Thielens N; Malissen B; Bonneville M; Housset D
J Immunol; 2009 Jul; 183(1):430-7. PubMed ID: 19542454
[TBL] [Abstract][Full Text] [Related]
29. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
30. Analysis of specificity for antigen, Mls, and allogenic MHC by transfer of T-cell receptor alpha- and beta-chain genes.
Kaye J; Hedrick SM
Nature; 1988 Dec; 336(6199):580-3. PubMed ID: 2849059
[TBL] [Abstract][Full Text] [Related]
31. Transgenic TCR expression: comparison of single chain with full-length receptor constructs for T-cell function.
Zhang T; He X; Tsang TC; Harris DT
Cancer Gene Ther; 2004 Jul; 11(7):487-96. PubMed ID: 15153936
[TBL] [Abstract][Full Text] [Related]
32. Alloreactive T cell recognition of MHC class I molecules: the T cell receptor interacts with limited regions of the MHC class I long alpha helices.
Smith KD; Lutz CT
J Immunol; 1997 Mar; 158(6):2805-12. PubMed ID: 9058816
[TBL] [Abstract][Full Text] [Related]
33. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
[TBL] [Abstract][Full Text] [Related]
34. Structural studies on the alphabeta T-cell receptor.
Ely LK; Kjer-Nielsen L; McCluskey J; Rossjohn J
IUBMB Life; 2005 Aug; 57(8):575-82. PubMed ID: 16118115
[TBL] [Abstract][Full Text] [Related]
35. Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. Inhibition by anti-L3T4 antibodies is a function both of epitope density and mode of presentation of anti-receptor antibody.
Owens T; Fazekas de St Groth B
J Immunol; 1987 Apr; 138(8):2402-9. PubMed ID: 2435798
[TBL] [Abstract][Full Text] [Related]
36. Production of soluble alphabeta T-cell receptor heterodimers suitable for biophysical analysis of ligand binding.
Willcox BE; Gao GF; Wyer JR; O'Callaghan CA; Boulter JM; Jones EY; van der Merwe PA; Bell JI; Jakobsen BK
Protein Sci; 1999 Nov; 8(11):2418-23. PubMed ID: 10595544
[TBL] [Abstract][Full Text] [Related]
37. Production of soluble MHC class II proteins with covalently bound single peptides.
Kozono H; White J; Clements J; Marrack P; Kappler J
Nature; 1994 May; 369(6476):151-4. PubMed ID: 8177320
[TBL] [Abstract][Full Text] [Related]
38. Changing the peptide specificity of a human T-cell receptor by directed evolution.
Smith SN; Wang Y; Baylon JL; Singh NK; Baker BM; Tajkhorshid E; Kranz DM
Nat Commun; 2014 Nov; 5():5223. PubMed ID: 25376839
[TBL] [Abstract][Full Text] [Related]
39. An integrated approach to extreme thermostabilization and affinity maturation of an antibody.
McConnell AD; Spasojevich V; Macomber JL; Krapf IP; Chen A; Sheffer JC; Berkebile A; Horlick RA; Neben S; King DJ; Bowers PM
Protein Eng Des Sel; 2013 Feb; 26(2):151-64. PubMed ID: 23173178
[TBL] [Abstract][Full Text] [Related]
40. Selection of functional T cell receptor mutants from a yeast surface-display library.
Kieke MC; Shusta EV; Boder ET; Teyton L; Wittrup KD; Kranz DM
Proc Natl Acad Sci U S A; 1999 May; 96(10):5651-6. PubMed ID: 10318939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]